- Adcom lights the way toward approval of first U.S. gene therapy in rare disease
- NIH, biopharmas launch PACT to improve cancer biomarker testing
- Human interest story: CRL wants Acelrx data on dose, text to prevent device flubs
- ‘Sprucing’ up the place: $20M series A takes lead asset into phase II in CAH
- HARP to seek high-risk science, infrastructure t...
The amount of cash generated by global public and private biopharmaceutical companies was up significantly in the third quarter compared to the second quarter. The almost $16 billion haul was 45 percent higher than the $11 billion raised during the second quarter and almost 25 percent higher than the total generated in the same period last year. Thanks to their higher company valuations, public companies were able to conduct public offerings with confidence, and the amount of private capital raised ballooned to more than $3.23 billion – a 61 percent increase over the $2 billion generated in the second quarter of this year.
One of the challenges for weight loss is that the body is evolutionarily programmed to worry about famines, not feasts. As a result, losing weight, if not exactly easy, is achievable for many individuals. Keeping that weight off, though, is a formidable challenge, because weight loss sets off powerful compensatory mechanisms in the body. (See BioWorld, Sept. 26, 2017.)
READ MORE »- 'Brutal test' shows partial protein can reverse Rett syndrome »
- Synthetic antibody-based GPCR endocytosis inhibitor developed, study shows »
- Crystal-clear images, no crystal required »
- Stem cell-derived EPO-producing cells can ameliorate renal anemia »
- New method maps long-range gene regulation »
- Approach may prevent hair loss from cancer therapy »
- Gene therapy helps formerly rotund rodents keep off the weight »
- Carbohydrates may hold key to improved malaria vaccine »
- Gene therapy scope broadens, again, with immune tolerance work »
- Drug quality from a patient’s perspectiveSeptember 10, 2017 | 2:06 PM | Posted by: Mari Serebrov
- Importation a cliché, not a CAPAAugust 04, 2017 | 11:08 PM | Posted by: Mari Serebrov
- Life and death and #BIO2017June 26, 2017 | 10:18 PM | Posted by: Marie Powers
- No choice, no free marketJune 20, 2017 | 6:35 PM | Posted by: Mari Serebrov
- Poverty, politics and preventable disease: Blurring the lines between truth and fiction in BioWorld’s 11th annual Summer Reading ListJune 01, 2017 | 4:13 PM | Posted by: Marie Powers
Partners in Focus
